PHG

Business Context and Reporting Period

Company: Koninklijke Philips Electronics N.V. (Royal Philips Electronics)
Filing Type: Form 20-F (Annual Report)
Reporting Period: Fiscal year ended December 31, 2006
Business Overview: Philips operates globally in Medical Systems, Domestic Appliances and Personal Care (DAP), Consumer Electronics (CE), Lighting, and Other Activities. The company is headquartered in Amsterdam, The Netherlands, with operations in over 50 countries. The 2006 financial statements are prepared in accordance with US GAAP.

Key Financial Metrics (2006)

Note: The significant increase in Net Income (EUR 5,383 million) compared to 2005 (EUR 2,868 million) is primarily driven by EUR 4,464 million in income from discontinued operations, largely related to the sale of the Semiconductors division. Income from continuing operations was EUR 919 million.

Material Changes vs. Prior Period (2005)

• Revenue: Sales increased to EUR 26,976 million in 2006 from EUR 25,775 million in 2005 (approx. 4.7% growth).
• Profitability: Income from Operations (EBIT) decreased to EUR 1,183 million in 2006 from EUR 1,472 million in 2005. The EBIT margin declined to 4.4% from 5.7%.
• Discontinued Operations: The Semiconductors division was classified as a discontinued operation. The 2006 results include a massive gain from the sale of this division, inflating total Net Income significantly compared to continuing operations.
• Cash Flow: Net cash provided by operating activities dropped sharply to EUR 342 million in 2006 from EUR 1,141 million in 2005. Net cash used for investing activities was EUR 2,811 million in 2006, compared to a net inflow of EUR 1,687 million in 2005.
• Debt: Total debt decreased slightly. The company maintained a net cash position (cash and cash equivalents net of debt) at the end of 2006, similar to the net cash position held at the end of 2005 (EUR 806 million).

Guidance, Outlook, and Risks

Dividend Policy: Philips aims for a sustainable dividend reflecting a distribution of 40% to 50% of continuing net income. A proposal was submitted to declare a dividend of EUR 0.60 per Common Share for 2006 (approx. EUR 630 million total).

Outlook and Strategy: Management continues to focus on the "Business Renewal Program" to improve margins and asset efficiency. The company is shifting focus toward healthcare and lifestyle sectors. The sale of the Semiconductors division (completed in 2006) marks a strategic pivot away from that business.

Risks and Contingencies:

• Market Risks: Exposure to exchange rate fluctuations (Euro vs. US Dollar and other currencies) and interest rate changes.
• Operational Risks: Dependence on consumer and business spending in major economies, raw material costs, and technological changes.
• Legal and Environmental: Pending legal proceedings and environmental remediation obligations which require significant judgment in estimating liabilities.
• Pension Costs: Sensitivity to changes in discount rates and return on assets assumptions for pension obligations.

Key Facts for Investor Verification

• Quality of Earnings: Verify the distinction between Net Income (heavily influenced by the one-time sale of the Semiconductors division) and Income from Continuing Operations (EUR 919 million), which better reflects ongoing operational performance.
• Cash Flow Deterioration: Investigate the sharp decline in operating cash flow (from EUR 1.14 billion in 2005 to EUR 342 million in 2006) and the significant cash outflow from investing activities.
• EBIT Margin Compression: Analyze the reasons for the decline in EBIT margin from 5.7% in 2005 to 4.4% in 2006, specifically regarding restructuring costs and R&D expenditures.
• Share Repurchases: Confirm the impact of the share repurchase program (approx. 106 million shares purchased in 2006) on earnings per share and capital structure.
• Discontinued Operations: Ensure financial models exclude the EUR 4.46 billion gain from discontinued operations when forecasting future recurring earnings.